Scholars Central

Conference abstract

Micro vesicles secreted by nitric oxide primed mesenchymal stromal cells boost the engraftment potential of hematopoietic stem cells

Authors: Vaijayanti Kale

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Patients with leukemia, lymphoma, severe aplastic anemia, etc. are frequently the targets of bone marrow transplantation, success of which critically depends on efficient engraftment by transplanted hematopoietic cells (HSCs). Early recovery of hematopoiesis is of paramount importance to reduce the post-transplant morbidity and mortality. In autologous settings, HSCs are collected from the patients in remission. These HSCs are already exposed to chemotherapeutic agents, and thus, may possess affected functionality. Similarly, HSCs from older individuals possess compromised engraftment ability due to aging process. Cord blood units yield fewer HSCs, restricting their use to pediatric patients. Ex vivo manipulation of HSCs to improve their engraftment ability becomes necessary when the number or quality of donor HSCs is a limiting factor. Due to their hematopoiesis-supportive ability, bone marrow-derived mesenchymal stromal cells (MSCs) have been traditionally used as feeder layers for ex vivo expansion of HSCs. MSCs form a special HSC-niche in vivo, implying that signaling mechanisms operative in them would affect HSC fate. We have recently demonstrated that AKT signaling prevailing in the MSCs affect the HSC functionality. Here we show that MSCs primed with nitric oxide donors significantly boosts the engraftment potential of the HSCs co-cultured with them via horizontal transfer of mRNAs encoding HSCsupportive genes via microvesicles (MVs). Our data suggest that these MVs could be used as HSC-priming agents to improve transplantation efficacy. Since both, nitric oxide donors and MSCs are already in clinical use; their application in clinical settings may be relatively straight forward. This approach could also be applied in regenerative medicine protocols.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Stem Cell Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Vaijayanti Kale”